• While Praxis moves forward, Neurocrine drops its essential tremor drug

    1 day ago - By San Diego Biotechnology

    While Neurocrine Biosciences continues to grow the sales of its tardive dyskinesia drug for patients who experience uncommon side effects from mental health drugs, it hit a snag in its development of an essential tremor...
    Read more ...